Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy

AU Neumann, NP Lam, H Dahari, DR Gretch, TE Wiley… - Science, 1998 - science.org
AU Neumann, NP Lam, H Dahari, DR Gretch, TE Wiley, TJ Layden, AS Perelson
Science, 1998science.org
To better understand the dynamics of hepatitis C virus and the antiviral effect of interferon-α-
2b (IFN), viral decline in 23 patients during therapy was analyzed with a mathematical
model. The analysis indicates that the major initial effect of IFN is to block virion production
or release, with blocking efficacies of 81, 95, and 96% for daily doses of 5, 10, and 15 million
international units, respectively. The estimated virion half-life (t 1/2) was, on average, 2.7
hours, with pretreatment production and clearance of 1012 virions per day. The estimated …
To better understand the dynamics of hepatitis C virus and the antiviral effect of interferon-α-2b (IFN), viral decline in 23 patients during therapy was analyzed with a mathematical model. The analysis indicates that the major initial effect of IFN is to block virion production or release, with blocking efficacies of 81, 95, and 96% for daily doses of 5, 10, and 15 million international units, respectively. The estimated virion half-life (t 1/2) was, on average, 2.7 hours, with pretreatment production and clearance of 1012 virions per day. The estimated infected cell death rate exhibited large interpatient variation (corresponding t 1/2 = 1.7 to 70 days), was inversely correlated with baseline viral load, and was positively correlated with alanine aminotransferase levels. Fast death rates were predictive of virus being undetectable by polymerase chain reaction at 3 months. These findings show that infection with hepatitis C virus is highly dynamic and that early monitoring of viral load can help guide therapy.
AAAS